Most Recent
Viagogo lured customers in with false claims, court hears
A four-day trial against online ticket reseller Viagogo kicked off Monday, with the ACCC describing how the site misled consumers by falsely claiming it was an official ticket vendor, hitting them with a booking fee of around 28 per cent along the way.
Heinz drops appeal in sugary kids snacks case
H.J. Heinz Company has dropped its appeal of a ruling that it marketed its sugary snacks to kids as healthy, after the ACCC won a fraction of the $10 million fine it sought for the consumer law violations.
Slater and Gordon wins $12.7M in fees in Provident class action
The NSW Supreme Court has approved a $44.25 million settlement of two class actions against the trustees of failed debenture issuer Provident Capital, including $12.8 million in legal fees for Slater and Gordon and $4.3 million for funder Litman Holdings.
Hastie liquidators pick two test cases over unpaid bills, but stay bid coming
Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.
Bannister Law off Ford class action in wake of funder feud
Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that's backing the case.
Apotex settles patent suit over generic Lexapro
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
AFT Pharma’s Maxigesic ads misleading, judge rules
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
Wyeth resolves Commonwealth’s claims over generic Effexor delay
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Goodyear hits the brakes on trade mark appeal against Dunlop
US tyre company Goodyear has dropped its challenge to a mixed trade mark ruling in its long-running dispute with UK-based rival Dunlop over coveted trade marks for 'Dunlop' and 'Flying D'.
Fortescue unit can eyeball Squire Patton Boggs emails in power contract dispute
A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs  and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.